Early Alert: Electrophysiology Catheter Issue from Medline ReNewal
Early Alert: WATCHMAN Access System Issue from Boston Scientific
FDA Names Top HHS Lawyer as Chief Counsel
FDA Names Top HHS Lawyer as Chief Counsel
http://www.fda.gov/news-events/press-announcements/fda-names-top-hhs-lawyer-chief-counsel
FDA is Requiring Opioid Pain Medicine Manufacturers to Update Prescribing Information Regarding Long-Term Use: Drug Safety Communication
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
http://www.fda.gov/news-events/press-announcements/fda-requires-major-changes-opioid-pain-medication-labeling-emphasize-risks
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
http://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
http://www.fda.gov/news-events/press-announcements/fda-recommends-removal-voluntary-hold-elevidys-ambulatory-patients
FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys
FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys
http://www.fda.gov/news-events/press-announcements/fda-investigating-death-8-year-old-boy-who-received-elevidys